 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
1 X% b) {' T; Y; O. |5 v) E 2 _, K7 T6 Q' C& C; n& q2 N
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
" J9 R( n. O! T; z
3 C3 K- C; y# |9 ^& i9 ?& sBY THE EDMONTON JOURNAL FEBRUARY 16, 2007. v, Y4 v0 w5 L" Y) `# f H9 _
( d) A) I Q( {& `$ o
1 [* o( G! a8 Z0 a
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
; N5 l) }( G2 ^- w
/ ?' k' e+ {/ s# P! Z2 lThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."1 E* s8 g3 O8 R0 p
4 I+ j! a, @' |! @: p( |2 GThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
2 ?% A* P0 M' s5 `/ G
8 B+ D; Q& Q% ^3 S' [& nIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.6 l5 B" o; M- I" w
: p& v0 M6 {+ b( p3 b- mIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.: I, \# _- A* W& @. @
( ~ B; R' o; O, A/ _"As a scientist, it's one of the highlights of my CAREER," Shan said.$ a0 U; J% a8 X( X+ _0 ^' G
* G+ C* I5 o, E. d# j; n4 T& y" s% I"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."/ P7 U( P& s9 L( T1 x& f M# {
$ A" [$ g. u% g0 Y* yIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.: M' _9 N* I+ ^ [1 H
; D o g, ^ V; I1 f2 gGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
1 F9 B8 l4 F% R
* Z6 X6 E$ A' Z, NThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
) E* R- R3 _/ M) ~/ T! `
6 L" G& O L' z1 X: b" b: J+ b5 n# n
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
